Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May;28(5):209-216.
doi: 10.1038/s41434-020-0168-2. Epub 2020 Jun 19.

Retinal gene therapy: an eye-opener of the 21st century

Anne Louise Askou #  1 , Thomas Stax Jakobsen #  2 , Thomas J Corydon  3   4
Affiliations

Retinal gene therapy: an eye-opener of the 21st century

Anne Louise Askou et al. Gene Ther. 2021 May.
No abstract available

PubMed Disclaimer

References

    1. High KA, Roncarolo MG. Gene therapy. N Engl J Med. 2019;381:455–64. - PubMed
    1. Trapani I, Auricchio A. Seeing the light after 25 years of retinal gene therapy. Trends Mol Med. 2018;24:669–81. - PubMed
    1. Garafalo AV, Cideciyan AV, Heon E, Sheplock R, Pearson A, WeiYang Yu C, et al. Progress in treating inherited retinal diseases: early subretinal gene therapy clinical trials and candidates for future initiatives. Prog Retin Eye Res. 2019:100827. [Online ahead of print].
    1. Trapani I, Auricchio A. Has retinal gene therapy come of age? From bench to bedside and back to bench. Hum Mol Genet. 2019;28:R108–18. - PubMed - PMC
    1. Russell S, Bennett J, Wellman JA, Chung DC, Yu ZF, Tillman A, et al. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Lancet. 2017;390:849–60. - PubMed - PMC

Publication types

LinkOut - more resources